Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity
about
Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosisSafety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study.Cytokines in the immunopathology of systemic sclerosis.
P2860
Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity
description
scientific article published on 25 July 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2014
@uk
name
Serum free light chains of imm ...... ristics, activity and severity
@en
Serum free light chains of imm ...... ristics, activity and severity
@nl
type
label
Serum free light chains of imm ...... ristics, activity and severity
@en
Serum free light chains of imm ...... ristics, activity and severity
@nl
prefLabel
Serum free light chains of imm ...... ristics, activity and severity
@en
Serum free light chains of imm ...... ristics, activity and severity
@nl
P2093
P50
P1433
P1476
Serum free light chains of imm ...... ristics, activity and severity
@en
P2093
Aurélia Lanteri
Carine Hauspie
Carole Langlois
Pierre-Yves Hatron
Sandrine Morell-Dubois
P304
P356
10.1016/J.AUTREV.2014.07.003
P50
P577
2014-07-25T00:00:00Z